国家集中带量采购药品的短缺情况分析与对策建议
x
请在关注微信后,向客服人员索取文件
篇名: | 国家集中带量采购药品的短缺情况分析与对策建议 |
TITLE: | Analysis of the shortage of drugs in national centralized volume-based procurement and countermeasures and suggestions |
摘要: | 目的 分析国家集中带量采购(以下简称“集采”)药品在医疗机构的短缺情况及原因,为优化集采规则和完善药品短缺供应保障体系提出对策建议。方法提取全国医药信息网短缺数据库2019年1月-2021年12月前5批集采药品的短缺信息,对短缺频次、短缺品种及短缺原因等进行描述性统计分析。结果与结论前5批国家集采落地后中选品规药品及中选企业药品短缺报告频次均明显增加,且以中选企业药品短缺报告为主。中选企业药品部分品种在集采落地短期内短缺情况明显,多为临床常用药品。集采药品短缺的发生受生产、流通、使用各环节的影响,短缺原因复杂多样,原料药短缺或垄断为主要因素。为保障国家集采药品的供应,建议科学评估企业断供风险,进一步优化集采规则,完善药品短缺报告制度,并关注集采重点药品供应情况;此外,医疗机构应在政策范围内采取多种措施,灵活应对药品短缺的问题,以免贻误患者治疗。 |
ABSTRACT: | OBJECTIVE To analyze the situation and causes of the shortage of drugs in centralized volume-based procurement, and to put forward countermeasures and suggestions for optimizing centralized procurement rules and improving the drug shortage supply guarantee system. METHODS The shortage data of the first five batches of centralized purchasing drugs during January 2019 and December 2021 were collected from the Shortage Database of Chinese medicine economic information; descriptive statistical analysis was performed for shortage frequency, varieties and reasons. RESULTS & CONCLUSIONS After the first five batches of centralized volumetric procurement policy landed, the frequency of drug shortage reported for selected specifications and selected enterprises increased significantly, mainly drug shortage of selected enterprises. The shortage of some varieties from selected enterprises in the short term was obvious, and most of them were commonly used clinical drugs. The occurrence of drug shortages was affected by various links such as the production, circulation and use, and the main reasons were shortage or monopoly of raw materials. In order to ensure the drugs supply, the government should scientifically assess the risk of production interruption of enterprises, further optimize centralized procurement rules, improve the reporting system for drug shortages, and attach importance to the supply of key drugs; in addition, hospitals should take a variety of measures within the scopes of policies to flexibly respond to drug shortages so as to avoid delaying the treatment of patients. |
期刊: | 2023年第34卷第07期 |
作者: | 周德雨;蒯丽萍;徐冬艳;田丽娟 |
AUTHORS: | ZHOU Deyu,KUAI Liping,XU Dongyan,TIAN Lijuan |
关键字: | 药品短缺;国家集中带量采购;集采药品;供应保障 |
KEYWORDS: | drug shortage; national centralized volume-based procurement; centralized purchasing drugs; supply support |
阅读数: | 419 次 |
本月下载数: | 22 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!